Age-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 50, affecting approximately 1.4 million Canadians. There are two kinds of AMD: dry AMD which…

Valproic acid (VA), belongs to a family of drugs called HDAC inhibitors (HDACi) and has been tested as a potential treatment for retinitis pigmentosa (RP) with mixed results. In some clinical trials,…

Introduction My name is Marlene Cust. I am a senior citizen, and legally blind due to retinitis pigmentosa (RP) and age-related macular degeneration (AMD). In my writing, I want to acknowledge both…

May is Vision Health Month! Did you know that three out of four cases of vision loss are preventable—but only if they’re treated early? That’s why Fighting Blindness Canada (FBC) is partnering…

FBC-funded researcher, Dr. Philippe Monnier identifies new treatment to stop photoreceptor cells from dying. Research published in March 2020 in The Journal of Clinical Investigation has identified a new target that may…

Dr. Tianwei Zhou has been announced as this year’s winner of Fighting Blindness Canada’s Clinician Scientist Emerging Leader (CSEL) award. Dr. Zhou is an ophthalmology resident from the Université de Montréal. Mentored…